iCardio.ai

📍 Los Angeles, United States🗓 Founded 2019👥 11 employees💰 Last funded Aug 2023
Software Development🌐 icardio.ai
Website LinkedIn
iCardio.ai develops AI for the interpretation of Ultrasound imaging, with a focus on echocardiograms. Leveraging a proprietary dataset of over 200M annotated Ultrasound images, comprising possibly the largest privately-owned Ultrasound database in the world, iCardio.ai’s mission ushers in the most cutting-edge innovation in the realm of deep medicine. iCardio.ai serves several leading Ultrasound software and hardware companies, including GE Healthcare, in the research and development of AI algorithms. iCardio.ai’s establishment coincides with the recent explosive use of hand-held portable Ultrasound across all areas of healthcare, perhaps the largest shift in medical imaging since the invention of the X-Ray, to provide real-time interpretation of images either on-device or through the cloud. Setting the standard for deep learning within medical imaging and expanding its potential applications, iCardio.ai is bringing AI to Ultrasound.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in iCardio.ai?
iCardio.ai has 2 investors on record on gritt.io, 2 mid-stage.
When did iCardio.ai last raise funding?
The most recent investment in iCardio.ai recorded on gritt.io was in August 2023.
When was iCardio.ai founded?
iCardio.ai was founded in 2019.
What industry is iCardio.ai in?
iCardio.ai operates in Software Development. Find similar Software Development investors on gritt.io.
Where is iCardio.ai based?
iCardio.ai is headquartered in Los Angeles, United States.